Race Oncology Limited (“Race”) announces Executive Director and Chief Scientific Officer (CSO), Dr Daniel Tillett has advised his decision to step down from his roles. Dr Tillett will provide ongoing…

Race is pleased to announce the appointment of global pharmaceutical and commercial leader, Mr Damian Clarke-Bruce, as Managing Director and Chief Executive Officer, effective 1 February 2023. Mr Phil Lynch…

Race-Submits-Human-Ethics-Application-to-Commence-Cardioprotection-Breast-Cancer-TrialDownload

Danny-Sharp-appointed-an-Independent-Non-Executive-Director-of-RaceDownload

Race Oncology 2022 AGM Presentation by CEO Phil Lynch and CSO Dr Daniel Tillett. https://youtu.be/sIgOxKGC6Cg